Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
195.00
Ask:
205.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

Business Update: COVID-19

23 Mar 2020 14:28

RNS Number : 2442H
Synectics PLC
23 March 2020
 

 

 

For immediate release

 

23 March 2020

 

 

Synectics plc

("Synectics" or "the Company")

 

Business Update: COVID-19

Synectics plc (AIM: SNX) provides the following update on the measures the Company is taking in response to the developing COVID-19 situation.

The Board is closely monitoring the effect Coronavirus (COVID-19) is having on Synectics' customers, business and employees, and are making necessary decisions daily to meet the rapidly changing situation.

The business has a solid cash position, and has measures already in place to ensure it remains financially sound during this period of uncertainty, and beyond.

Business Operations

The Company's business is to provide security and safety systems: Our employees and customers are acutely aware of the vital role they play in protecting communities around the world, and are making every effort to ensure our customers can rely on us at this difficult time.

Although we anticipate significant, unavoidable disruption, we are using best endeavours to continue essential service and support to our customers.

The priorities for the Board are to:

§ protect the health and well-being of our employees and customers;

§ provide ongoing support to our customers, especially where we are providing essential security and safety; and

§ manage our business for the long term by prudent actions to preserve cash and maintain capability.

Changes to Working Practices

As an International business, we are closely following all National government regulations and guidance wherever we operate - regarding travel, working practices, 'stay home' notifications, healthcare, and well-being.

We have taken significant steps to protect colleagues and customers, while actioning robust continuity plans to minimise disruption - which we are constantly reviewing and updating.

We suspended all business travel at the start of last week, re-arranged working patterns at all Synectics sites, and implemented measures such as increasing remote support, and ensuring our teams can work from home. 

Most employees are now working from home, or on rotation: with an expected significant and extended increase in homeworking, which many of our colleagues have no experience of, we have instigated a specific programme to keep colleagues connected to the business and each other, to facilitate continued teamwork and avoid feelings of isolation.

 

Financial Position

The business has a solid cash position. Currently available cash balance was £4.1M as of 20 March 2020, with confirmed facilities of £5M in place if required.

Measures have already been put in place to curb discretionary spending and to preserve cash. All recruitment and non-critical capital expenditures are on hold. Stocking plans are being adjusted daily based on customers' committed requirements.

These actions should ensure that the business remains financially sound during this period of uncertainty and beyond.

We also note and welcome the UK Government's "Coronavirus Job Retention Scheme" and we await further details on how this will operate.

 

AGM

The Company still expects to hold its Annual General Meeting ("AGM") on 23 April 2020, but the venue for this has been changed to its offices in Sheffield and proceedings will be broadcast online.

The Board would encourage all shareholders who wish to do so to vote online at www.signalshares.com rather than attend the AGM in person.

In order to reduce the risk of infection, the meeting will end immediately following the business of the AGM.

Instructions on proxy voting are attached to the Notice of Meeting enclosed with the 2019 Annual Report which has already been sent out to shareholders and which can be found on the Company's website.

 

Dividend

The Board has recommended the payment of a final dividend for the year ended 30 November 2019 of 3.5p per share, subject to approval by shareholders at the Company's AGM on 23 April 2020.

Given the current situation and the desire to preserve cash, the Board believes it is appropriate and prudent to cancel the final dividend payment for the year ended 30 November 2019 and therefore intends to withdraw the relevant resolution at the AGM.

The Board will review the situation later in the year.

 

Outlook

The priorities for the Board are as set out above. We are a global business with a solid balance sheet, and we have taken immediate measures to contain costs and protect our financial position.

Modest trading in Q1 was expected to be followed by a strong Q2 performance. However given the continued uncertainty, the Board wishes to withdraw financial guidance on expected trading performance for the financial year ending 30 November 2020.

The Board will continue to monitor the situation closely and provide a further update at the time of the AGM on 23 April 2020.

 

Paul Webb

Chief Executive

 

23 March 2020

For further information, please contact:

Synectics plc

Tel: +44 (0) 114 280 2828

Paul Webb, Chief Executive

 

David Bedford, Finance Director

 

email: info@synecticsplc.com

www.synecticsplc.com

 

 

Shore Capital

Tel: +44 (0) 20 7408 4050

Tom Griffiths / Henry Willcocks

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDEALDDAALEEFA
Date   Source Headline
15th Jun 20263:44 pmRNSEBT Share Purchase
12th Jun 20263:54 pmRNSDirector/PDMR Shareholding
8th Jun 20267:00 amRNSEBT Share Purchase
1st Jun 20261:48 pmRNSEBT Share Purchase
20th May 20267:00 amRNSFunding of EBT to Acquire Ordinary Shares and RPT
18th May 202612:48 pmRNSResult of AGM
18th May 20267:01 amRNSBoard Change
18th May 20267:00 amRNSAGM Trading Update
23rd Apr 20261:30 pmRNSCorrection to Notice of Annual General Meeting
14th Apr 20267:00 amRNSPosting of Annual Report & Accounts, Notice of AGM
13th Mar 20262:05 pmRNSDirector dealings
12th Mar 20267:00 amRNSDirector Dealings
9th Mar 202610:20 amRNSDirector Dealings
3rd Mar 20263:30 pmRNSDirector / PCA Dealings
3rd Mar 20267:00 amRNSFinal Results and Strategic Update
24th Feb 202612:15 pmRNSNotice of Final Results and Investor Presentation
23rd Feb 20267:00 amRNSOngoing New Business Momentum
19th Feb 20261:41 pmRNSHolding(s) in Company
19th Jan 20269:00 amRNSHoldings in Company
18th Dec 202510:00 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSFull Year Trading Update
24th Nov 20257:00 amRNS-RExtension of Framework Agreement with Stagecoach
3rd Nov 20257:00 amRNS£1.8 million contract with Bus Eireann
16th Oct 20257:01 amRNSNew Contracts - Traction in Broader Energy Sector
16th Oct 20257:01 amRNSTrading Update
16th Oct 20257:00 amRNSAppointment of Nominated Adviser and Sole Broker
9th Oct 202512:16 pmRNSDirector dealings
2nd Oct 20257:00 amRNSPDMR dealings
2nd Sep 20257:00 amRNSDirector/PDMR Shareholding
29th Aug 20257:00 amRNSPDMR dealings
16th Jul 20257:00 amRNSLeisure & Hospitality Contract Wins
8th Jul 20257:00 amRNSHalf-year Report
19th Jun 20257:00 amRNSAppointment of Chief Financial Officer
9th Jun 20257:00 amRNSTrading Update and Notice of Results
4th Jun 20257:00 amRNSUS$4.8m Contract Extension
21st May 20257:00 amRNSPDMR Dealings
12th May 20257:00 amRNS£1.1 million Contract Award
7th May 20251:00 pmRNSResult of Annual General Meeting
7th May 20257:00 amRNSAGM Trading Update
2nd Apr 20257:00 amRNSPDMR dealings
1st Apr 20257:00 amRNSPosting of Annual Report & Accounts, Notice of AGM
31st Mar 20257:00 amRNS£2.0 million Award
4th Mar 20257:00 amRNSFinal Results
14th Feb 20257:00 amRNSNotice of Final Results and Investor Presentation
27th Jan 20257:00 amRNS$2.2 million Contract Award
13th Jan 20255:30 pmRNSHoldings in Company
6th Jan 20258:40 amRNSHoldings in Company
6th Jan 20258:30 amRNSHoldings in Company
9th Dec 20241:30 pmRNSHoldings in Company
9th Dec 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.